Comparison of HIV-, HBV-, HCV- and co-infection prevalence between Chinese and Burmese intravenous drug users of the China-Myanmar border region
about
HCV Diversity among Chinese and Burmese IDUs in Dehong, Yunnan, ChinaA multicentre molecular analysis of hepatitis B and blood-borne virus coinfections in Viet NamHigh prevalence of HIV, HCV, HBV and co-infection and associated risk factors among injecting drug users in Yunnan province, ChinaDiverse forms of HIV-1 among Burmese long-distance truck drivers imply their contribution to HIV-1 cross-border transmission.Prevalence of hepatitis B and C viral co-infections among HIV-1 infected individuals in Nairobi, Kenya.The geographic distribution patterns of HIV-, HCV- and co-infections among drug users in a national methadone maintenance treatment program in Southwest China.Viral hepatitis and human immunodeficiency virus co-infections in AsiaSeroepidemiology of hepatitis B virus infection and impact of vaccination.An HIV Vaccine for South-East Asia-Opportunities and Challenges.Are females who inject drugs at higher risk for HIV infection than males who inject drugs: an international systematic review of high seroprevalence areasGeographical variations in risk factors associated with HIV infection among drug users in a prefecture in Southwest China.A novel multiplex isothermal amplification method for rapid detection and identification of viruses.Triple positivity of HBsAg, anti-HCV antibody, and HIV and their influence on CD4+ lymphocyte levels in the highly HIV infected population of Abeokuta, Nigeria.HIV/AIDS patients' medical and psychosocial needs in the era of HAART: a cross-sectional study among HIV/AIDS patients receiving HAART in Yunnan, China.Heme and HO-1 Inhibition of HCV, HBV, and HIV.Multiple infections and cancer: implications in epidemiology.HIV-associated pulmonary arterial hypertension: from bedside to the future.Epidemiological profile and risk factors of HIV and HBV/HCV co-infection in Fujian Province, southeastern China.Hepatitis B screening and prevalence among resettled refugees - United States, 2006-2011.Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.Computational analysis to predict functional role of hsa-miR-3065-3p as an antiviral therapeutic agent for treatment of triple infections: HCV, HIV-1, and HBV.Prevalence of hepatitis C and B virus among patients infected with HIV: a cross-sectional analysis of a large HIV care programme in Myanmar.Immunogenicity and safety of high-dose hepatitis B vaccine among drug users: A randomized, open-labeled, blank-controlled trial.Burmese injecting drug users in Yunnan play a pivotal role in the cross-border transmission of HIV-1 in the China-Myanmar border region
P2860
Q27468608-A4F847EA-C119-4425-AD86-BF7BDBA3995AQ28480392-289ADA22-89BF-4DF7-A99B-42B4E617AE56Q28482312-354DCCCE-C878-4D7A-B78D-CADD877E12E5Q34123609-2C65183F-F6D8-45CA-9ACB-D1F455010ED0Q34982182-9DE59A04-8EDD-4C7C-9368-7EEB34D537FAQ35115722-6FCD1E72-E8E1-4031-B778-6C29424FD780Q35567832-A6753C63-6F17-491E-80D8-5FED51AFFD2FQ35819579-7B4FD441-5D67-4A7A-A368-E11ACF847429Q35826681-57EA11E2-E3A0-4AB6-BA86-885E3EB96C6AQ35962535-929F0DC6-B1A5-41DB-85C0-2720AADEF8DAQ36020195-34456B0B-1779-4477-9D64-4DD4F8294C64Q36353554-550494DA-415D-45AC-BF8B-29385B5ABDE9Q36612848-BC4CB764-17B5-4FA5-A462-9AA53B17389DQ36652189-2E3BB20D-A635-4A70-909A-6BFA5661B465Q38051629-50236955-0C6C-43D0-A85F-4D304A3A99CFQ38126931-CC464E03-37B8-4C08-99D1-4BBFB3167979Q38365222-575555B3-1E81-4533-8DE3-9D581B44967CQ40566052-FBD5CB5E-937E-4EE9-B485-2B30962AB3AEQ40870052-B58FC2C9-3046-475C-9A2D-225F3B130CB4Q41524630-323F3246-02FE-4FF6-A178-59F976E4F5DAQ41902865-E93A7D8D-543C-4A58-9BD8-E9A3DF78AE83Q42288181-919E0991-2AD9-4ACA-964F-7CB87AD7E9CCQ54408166-82F45961-BAD6-4F2C-B579-11681A8922AAQ58806134-5C118999-BC76-4C13-81CD-EF6B6E73E963
P2860
Comparison of HIV-, HBV-, HCV- and co-infection prevalence between Chinese and Burmese intravenous drug users of the China-Myanmar border region
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Comparison of HIV-, HBV-, HCV- ...... he China-Myanmar border region
@ast
Comparison of HIV-, HBV-, HCV- ...... he China-Myanmar border region
@en
Comparison of HIV-, HBV-, HCV- ...... he China-Myanmar border region
@nl
type
label
Comparison of HIV-, HBV-, HCV- ...... he China-Myanmar border region
@ast
Comparison of HIV-, HBV-, HCV- ...... he China-Myanmar border region
@en
Comparison of HIV-, HBV-, HCV- ...... he China-Myanmar border region
@nl
prefLabel
Comparison of HIV-, HBV-, HCV- ...... he China-Myanmar border region
@ast
Comparison of HIV-, HBV-, HCV- ...... he China-Myanmar border region
@en
Comparison of HIV-, HBV-, HCV- ...... he China-Myanmar border region
@nl
P2093
P2860
P3181
P1433
P1476
Comparison of HIV-, HBV-, HCV- ...... he China-Myanmar border region
@en
P2093
Feng-Liang Liu
Yan-Heng Zhou
Yong-Tang Zheng
Zhi-Hong Yao
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0016349
P407
P577
2011-01-21T00:00:00Z